KEGG   DRUG: Lifastuzumab
Entry
D11237                      Drug                                   
Name
Lifastuzumab (USAN)
Formula
C6504H10028N1744O2018S46
Exact mass
146324.2835
Mol weight
146414.77
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFSFS DFAMSWVRQA PGKGLEWVAT IGRVAFHTYY
PDSMKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARHR GFDVGHFDFW GQGTLVTVSS
ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
QQGNVFSCSV MHEALHNHYT QKSLSLSPG
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRSSETLV HSSGNTYLEW YQQKPGKAPK LLIYRVSNRF
SGVPSRFSGS GSGTDFTLTI SSLQPEDFAT YYCFQGSFNP LTFGQGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H147-H203, H223-L219, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'219, H'264-H'324, H'370-H'428, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Antineoplastic, Anti-NaPi-IIb antibody
  Type
Monoclonal antibody
Target
SLC34A2 [HSA:10568] [KO:K14683]
  Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Brite
Target-based classification of drugs [BR:br08310]
 Transporters
  Solute carrier family
   SLC34
    SLC34A2
     D11237  Lifastuzumab (USAN)
Other DBs
CAS: 1615697-16-9
PubChem: 384585215
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system